000 | 01978 a2200517 4500 | ||
---|---|---|---|
005 | 20250517183548.0 | ||
264 | 0 | _c20180723 | |
008 | 201807s 0 0 eng d | ||
022 | _a1873-6815 | ||
024 | 7 |
_a10.1016/j.exger.2017.10.023 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaluchnejadmojarad, Tourandokht | |
245 | 0 | 0 |
_aThe anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling. _h[electronic resource] |
260 |
_bExperimental gerontology _c12 2017 |
||
300 |
_a70-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xgenetics |
650 | 0 | 4 |
_aBrain _xpathology |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinase Type 2 _xmetabolism |
650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xmetabolism |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
650 | 0 | 4 |
_aGlucuronidase _xpharmacology |
650 | 0 | 4 | _aKlotho Proteins |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aOxidopamine |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
700 | 1 | _aEftekhari, Seyed-Mohammad | |
700 | 1 | _aJamali-Raeufy, Nida | |
700 | 1 | _aHaghani, Sobhan | |
700 | 1 | _aZeinali, Hossein | |
700 | 1 | _aRoghani, Mehrdad | |
773 | 0 |
_tExperimental gerontology _gvol. 100 _gp. 70-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exger.2017.10.023 _zAvailable from publisher's website |
999 |
_c27758069 _d27758069 |